Clinical features common to PRES-related conditions
Feature | Preeclampsia | Allo-BMT | SOT | I/S/S | Autoimmune Ds | Chemo/Ca |
---|---|---|---|---|---|---|
Immune system antigen challenge | + | + | + | + | + | + |
(Placenta) | (BMT) | (Transplant) | (Bacteria) | (Self?) | (Tumor Ag) | |
Microchimeric exchange | + | + | + | – | + | − |
T-cell activation | + | + | + | + | + | + |
Inflammatory cytokines: TNF-α, IL-1, IFN-γ | + | + | + | + | + | + |
Endothelial activation: p-selectin, e-selectin, ICAM-1, VCAM-1 | + | + | + | + | ? | ? |
Endothelin-1 up-regulation | + | + | + | + | ? | ? |
Endothelial injury: thrombocytopenia, schistocytes, LDH | + | + | + | + | + | ? |
Vascular instability: vasoconstriction, vasodilation | + | + | + | + | ? | ? |
Organ hypoperfusion | + | + | + | + | ? | ? |
MODS | + | + | + | + | + | ? |
VEGF elevation | + | ? | ? | ? | ? | ? |
Endothelial autoantibodies | + | + | + | – | + | − |
Note:—I/S/S indicates infection/sepsis/shock; += present; –, not present; ?, undetermined or not studied; Allo-BMT, allogeneic bone marrow transplant; SOT, solid organ transplant; TNF, tumor necrosis factor; IL-1, interleukin; IFN, interferin; ICAM-1, intercellular adhesion molecule 1; VCAM-1, vascular cell adhesion molecule 1; LDH, L-lactate dehydrogenase; MODS, multiorgan dysfunction syndrome; VEGF, vascular endothelial growth factor; Ds, disease; Chemo/Ca, post chemotherapy with cancer; Ag, unique tumor antigens.